Herpes Zoster Vaccination Rates in Hematological and Oncological Patients—Stock Taking 2 Years after Market Approval
- DOI
- 10.3390/healthcare10081524
- Published
- 2022-08-12
- Container
- Healthcare
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/healthcare10081524,
title = {Herpes Zoster Vaccination Rates in Hematological and Oncological Patients—Stock Taking 2 Years after Market Approval},
author = {Til Ramón Kiderlen and Katrin Trostdorf and Nicola Delmastro and Arne Salomon and Maike de Wit and Mark Reinwald},
year = {2022},
journal = {Healthcare},
doi = {10.3390/healthcare10081524},
url = {https://doi.org/10.3390/healthcare10081524}
}RIS
TY - JOUR TI - Herpes Zoster Vaccination Rates in Hematological and Oncological Patients—Stock Taking 2 Years after Market Approval AU - Til Ramón Kiderlen AU - Katrin Trostdorf AU - Nicola Delmastro AU - Arne Salomon AU - Maike de Wit AU - Mark Reinwald PY - 2022 JO - Healthcare DO - 10.3390/healthcare10081524 UR - https://doi.org/10.3390/healthcare10081524 ER -
APA
Kiderlen, T. R., Trostdorf, K., Delmastro, N., Salomon, A., Wit, M. D., & Reinwald, M. (2022). Herpes Zoster Vaccination Rates in Hematological and Oncological Patients—Stock Taking 2 Years after Market Approval. Healthcare. https://doi.org/10.3390/healthcare10081524
Source records
- crossref · retrieved 2026-11-07T19:29:10.994Z